Neurology· 2026Q1
Carotid Artery Stenting Is Now an Evidence-Based Adjunct to Intensive Medical Therapy for Stroke Prevention
- 1citations
- Q1SCImago
- 2026year
Short summary
Carotid artery stenting (CAS) combined with intensive medical management (IMM) significantly reduces stroke risk in patients with high-grade asymptomatic carotid stenosis compared to IMM alone, according to the CREST-2 trial.
AI-generated from the title and abstract; the full text is not read.
Key points
- CREST-2 trial shows CAS + IMM reduces stroke risk vs. IMM alone in high-grade asymptomatic carotid stenosis.
- Careful patient selection and operator skill are critical for successful CAS.
- CAS is validated as an important adjunct to IMM for stroke prevention.
- Shared decision-making is vital when considering CAS for asymptomatic stenosis.
AI-generated from the title and abstract; the full text is not read.
Abstract
The CREST-2 trial demonstrated that carotid artery stenting combined with intensive medical management (IMM) significantly reduces stroke risk in patients with high-grade asymptomatic carotid stenosis compared with IMM alone. Careful patient selection and operator skill are critical factors for procedural success and can provide real-world validation of stenting as an important adjunct to IMM for stroke prevention. Continued advances in medical management and stenting are expected. It remains vital to engage in shared decision-making when considering moving forward with stenting of asymptomatic carotid stenosis.
The authors' abstract, as published at the source. Neurology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pulmonary and Respiratory Medicine
Pulmonary and Respiratory MedicineMedicine